1. Home
  2. MPB vs PLRX Comparison

MPB vs PLRX Comparison

Compare MPB & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid Penn Bancorp

MPB

Mid Penn Bancorp

HOLD

Current Price

$34.33

Market Cap

827.5M

Sector

Finance

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.16

Market Cap

74.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPB
PLRX
Founded
1868
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
827.5M
74.9M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
MPB
PLRX
Price
$34.33
$1.16
Analyst Decision
Buy
Hold
Analyst Count
1
4
Target Price
$37.00
$2.67
AVG Volume (30 Days)
111.6K
537.0K
Earning Date
04-21-2026
05-06-2026
Dividend Yield
2.66%
N/A
EPS Growth
N/A
29.97
EPS
0.36
N/A
Revenue
N/A
N/A
Revenue This Year
$30.95
N/A
Revenue Next Year
$9.45
N/A
P/E Ratio
$94.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.21
$1.09
52 Week High
$35.22
$1.95

Technical Indicators

Market Signals
Indicator
MPB
PLRX
Relative Strength Index (RSI) 62.38 45.21
Support Level $30.82 $1.13
Resistance Level $34.88 $1.37
Average True Range (ATR) 0.77 0.05
MACD 0.23 -0.00
Stochastic Oscillator 96.96 24.14

Price Performance

Historical Comparison
MPB
PLRX

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc is a financial holding company, providing various banking and financial products and services through its subsidiaries. These products and services mainly include consumer banking products, including secure checking and savings accounts, mobile banking, agricultural loans, construction financing, mortgages, home equity loans and lines of credit, credit cards, and more. Additionally, the Group offers trust services, insurance products, wealth management, and private banking services. The Group caters to individuals, partnerships, non-profit organizations, and corporations through its retail banking offices located throughout Pennsylvania, with a minor portion in New Jersey.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: